Microsoft and Anthropic in Talks for Custom AI Chip Deal Following 5 Billion Investment NOXCAT Emphasizes Staking for LongTerm Ecosystem Growth Over ShortTerm Yield Jardines to Acquire Australian Radiology Leader in 24 Billion Deal Donald Trump JrBacked Enhanced Games Controversial Steroid Olympics Launches This Weekend with Broader Product Ambitions EU Plastic Bottle Cap Regulation A Case Study in Regulatory Value and Market Impact Wilson Sonsini Advises Greenhouse on Acquisition of Ezra AI Labs Zoetis ZTS Q1 2026 Earnings EPS Misses Estimates Despite Strong Stock Performance Dogwood Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued Preclinical Development MED Q1 2026 Earnings EPS Surprises with Smaller Loss Than Expected Genasys Inc GNSS Q1 2026 Earnings Strong EPS Surprise Drives Positive Market Response Sprinklr CXM Q1 2026 Earnings EPS Surges Past Estimates by 34 Despite Lack of Revenue Disclosure Omnicom Q1 2026 Earnings EPS Beats Estimates as Agency Demand Remains Resilient IB Acquisition Corp IBAC Slips Marginally as Stock Consolidates Near Support T Stamp Inc IDAI Surges 14 Key Levels and Momentum Analysis Celanese Corporation CE Holds Near Support Amid Broader Market Pressure Lulus Fashion Lounge LVLU Dips Nearly 4 as Stock Approaches Key Support Levels Nuburu Inc BURU Bounces From Support but Resistance Looms at 021 Nabtesco Targets EV Bus Market With AllElectric Power Steering Mass Production Alliant Energy LNT Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Rate Base Growth Arcelor Mittal MT Rallies 38 as Steel Sector Momentum Builds FCX Q1 2026 Earnings Strong Earnings Beat Amid Robust Copper Demand ONCY Q3 2025 Earnings WiderthanExpected Loss Amid Clinical Progress First Watch Restaurant Group Inc FWRG Q1 2026 Earnings EPS Miss Slightly Weighs on Sentiment AMPL Q1 2026 Earnings EPS Misses Estimates as Shares Rise Despite Challenging Quarter HDB Q1 2026 Earnings EPS Beats Estimates Amidst Market Skepticism HNI Q1 2026 Earnings Strong EPS Beat Amidst Operational Discipline PROK Q1 2026 Earnings Narrow Loss Beat Highlights Steady Progress in Cell Therapy Pipeline